Evidence map›Paper›PMID 41603044›Full record

ArticleCirculation. Genomic and precision medicine2026

Genetic Architecture of N-Terminal Pro-B-Type Natriuretic Peptide in a Multiancestry Study Population.

Naman S Shetty, Akhil Pampana, Mokshad Gaonkar, Amrita Nayak, Harshvir S Bal, Nirav Patel, Nehal Vekariya, J Gustav Smith, Alanna C Morrison, Bing Yu and 15 more

Abstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Naman S ShettyDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston (N.S.S.).ORCID 0000-0003-3600-126X
Akhil PampanaDivision of Cardiovascular Disease (A.P., A.N., H.S.B., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-4167-0540
Mokshad GaonkarDepartment of Biostatistics (M.G.), University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0003-0309-6813
Amrita NayakDivision of Cardiovascular Disease (A.P., A.N., H.S.B., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0001-9522-4717
Harshvir S BalDivision of Cardiovascular Disease (A.P., A.N., H.S.B., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham, Birmingham, AL.
Nirav PatelDivision of Cardiovascular Disease (A.P., A.N., H.S.B., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham, Birmingham, AL.
Nehal VekariyaDivision of Cardiovascular Disease (A.P., A.N., H.S.B., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham, Birmingham, AL.ORCID 0009-0002-3372-8375
J Gustav SmithThe Wallenberg Laboratory/Department of Molecular and Clinical Medicine, Institute of Medicine and Science for Life Laboratory, Gothenburg University, Sweden (J.G.S.).ORCID 0000-0001-6285-9935
Alanna C MorrisonHuman Genetics Center, University of Texas Health Science Center, Houston (A.C.M., B.Y., E.B.).ORCID 0000-0001-6381-4296
Bing YuHuman Genetics Center, University of Texas Health Science Center, Houston (A.C.M., B.Y., E.B.).ORCID 0000-0003-4818-1077
Bruce M PsatyCardiovascular Health Research Unit, Department of Medicine, Department of Epidemiology, Department of Health Systems and Population Health, University of Washington, Seattle (B.M.P., J.S.F.).ORCID 0000-0002-7278-2190
Eric BoerwinkleHuman Genetics Center, University of Texas Health Science Center, Houston (A.C.M., B.Y., E.B.).ORCID 0000-0001-8813-0544
James S FloydCardiovascular Health Research Unit, Department of Medicine, Department of Epidemiology, Department of Health Systems and Population Health, University of Washington, Seattle (B.M.P., J.S.F.).ORCID 0000-0002-0365-9041
Jerome I RotterDepartment of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA (J.I.R., K.D.T., X.G.).ORCID 0000-0001-7191-1723
Kent D TaylorDepartment of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA (J.I.R., K.D.T., X.G.).ORCID 0000-0002-2756-4370
Leslie A LangeDepartment of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora (L.A.L.).
Marguerite R IrvinDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham (M.R.I.).ORCID 0000-0002-1442-2023
Mary CushmanDepartment of Medicine, Larner College of Medicine at the University of Vermont, Burlington (M.C.).ORCID 0000-0002-7871-6143
Stephen S RichCenter for Public Health, University of Virginia, Charlottesville (S.S.R.).ORCID 0000-0003-3872-7793
Ramachandran S VasanUniversity of Texas School of Public Health San Antonio (R.S.V.).ORCID 0000-0001-7357-5970
Thomas J WangDepartment of Medicine, University of Texas-Southwestern Medical Center, Dallas (T.J.W.).ORCID 0000-0003-4063-6508
Xiuqing GuoDepartment of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA (J.I.R., K.D.T., X.G.).ORCID 0000-0002-5264-5068
Peng LiSchool of Nursing (P.L.), University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-9026-9999
Garima AroraDivision of Cardiovascular Disease (A.P., A.N., H.S.B., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0001-6402-6910
Pankaj AroraDivision of Cardiovascular Disease (A.P., A.N., H.S.B., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0003-2420-3550

Funding

Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood PressureR01HL160982 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.7M
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological StudyR01HL163081 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.7M
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black IndividualsR01HL163852 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.6M
Clinical Implementation of Blood Pressure Polygenic Risk Score: A Randomized Clinical TrialR01HL176882 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2025 to 2026
$1.5M
Mentored Patient-Oriented Research in Natriuretic Peptide System Based Precision Cardiometabolic HealthK24HL180320 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2025 to 2026
$265k
NHLBI NIH HHS K24 HL180320NHLBI NIH HHS R01 HL160982NHLBI NIH HHS R01 HL163081NHLBI NIH HHS R01 HL163852NHLBI NIH HHS R01 HL176882
6 · The paper itself

Abstract

backgroundNPs (natriuretic peptides) are bioactive hormones crucial for regulating blood pressure, glucose homeostasis, and lipid metabolism. Despite the high heritability of circulating NP levels, the genetic determinants of NP regulation, particularly across ancestries and sexes, remain poorly understood. The objective of the current study was to identify genetic variants associated with NT-proBNP (N-terminal pro-B-type NP) levels in a multiancestry study population.

methodsWhole genome sequencing and array-based data from 81 213 individuals without heart failure were analyzed from the Trans-Omics for Precision Medicine cohorts, UK Biobank, All of Us Research Program, and REGARDS (Reasons for Geographic and Racial Differences in Stroke) study to identify common, rare, and structural variants associated with NT-proBNP levels. The main outcome of the study was rank-based inverse normal and standardized NT-proBNP levels. Genetic associations with NT-proBNP were examined, followed by gene prioritization, transcriptome-wide association studies, colocalization, and rare variant analyses.

resultsNine novel loci and 3 previously reported loci were identified to be associated with NT-proBNP levels. Novel structural variants were detected across 12 loci. Similar effect sizes were observed for both common and rare variants. Key genes such as

conclusionsThis study identifies novel common, rare, and structural variants associated with NT-proBNP levels, highlighting the contribution of both coding and regulatory non-coding variation. These findings advance our understanding of the genetic architecture of NT-proBNP and may inform future cardiometabolic therapeutic strategies.

Indexed as

Natriuretic Peptide, BrainPeptide FragmentsAgedFemaleGenome-Wide Association StudyHumansMaleMiddle AgedPolymorphism, Single NucleotideNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)blood pressurecardiovascular diseasesgeneticsgenome-wide association studypeptidespolymorphism, single-nucleotidepro-brain natriuretic peptides

Identifiers

PMID41603044
PMCPMC13321388

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.